Humulene (α-humulene)

Humulene (α-humulene) is a monocyclic sesquiterpene found in hops, cannabis, and clove essential oils, identified by its 11-membered ring structure. Preclinical research suggests it exerts anti-inflammatory effects primarily through modulation of pro-inflammatory cytokine pathways and reactive oxygen species.

Origin & History

Humulene (α-humulene) is a naturally occurring monocyclic sesquiterpene (C₁₅H₂₄) found in numerous plants including hops (Humulus lupulus), cloves (Syzygium aromaticum), hemp, and eucalyptus as a constituent of their essential oils. It is commercially extracted via steam distillation or solvent extraction from plant material and purified to ≥96% purity using gas chromatography.

Historical & Cultural Context

No documented historical or traditional medicinal uses were found in the research for specific medical systems such as Ayurveda or TCM. Humulene's primary historical significance relates to its contribution to the hoppy flavor in beer and its sensory properties like providing a "watery note" in flavoring applications.

Health Benefits

• Anti-inflammatory activity suggested by preclinical studies in essential oils containing humulene (evidence quality: preliminary - animal studies only)
• Antiulcerogenic properties reported in preclinical contexts from Pterodon emarginatus seed oils (evidence quality: preliminary - no human trials)
• Potential antibacterial properties based on its sesquiterpenoid structure (evidence quality: preliminary - mechanism suggested but not detailed)
• May contribute to therapeutic properties of essential oils where it co-occurs with beta-caryophyllene (evidence quality: preliminary - compositional data only)
• Atmospheric reactivity properties that form secondary organic aerosols (evidence quality: not therapeutically relevant)

How It Works

Humulene is proposed to inhibit the NF-κB signaling pathway, thereby reducing transcription of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. It also appears to suppress cyclooxygenase (COX) enzyme activity, reducing prostaglandin synthesis in a manner analogous to non-steroidal anti-inflammatory mechanisms. Additionally, in vitro data from Pterodon emarginatus-derived oils suggest humulene contributes to gastroprotective effects by reducing oxidative stress at the gastric mucosal level, though the precise receptor targets remain unconfirmed in human tissue.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses for humulene were found in the research results. All available evidence comes from preclinical animal or in vitro studies, with no PubMed PMIDs provided for human trials.

Clinical Summary

No completed human clinical trials have evaluated isolated humulene as a standalone supplement. Preclinical evidence comes from rodent models using essential oils containing humulene (alongside β-caryophyllene and other sesquiterpenes), making it impossible to attribute effects to humulene alone. A study examining Pterodon emarginatus seed oil in animal models reported statistically significant reductions in gastric lesion indices, but humulene's individual contribution was not isolated. The current evidence base is preliminary and insufficient to establish efficacious dosing, meaningful clinical endpoints, or safety profiles in humans.

Nutritional Profile

{"macronutrients": {"protein": "Not applicable", "fiber": "Not applicable", "carbohydrates": "Not applicable", "fats": "Not applicable"}, "micronutrients": {"vitamins": "Not applicable", "minerals": "Not applicable"}, "bioactive_compounds": {"humulene": "Present in essential oils, concentration varies depending on the source (e.g., hops, basil, clove), typically ranging from 0.1% to 40% of the oil composition", "bioavailability_notes": "Humulene is a lipophilic compound, meaning it is more soluble in fats and oils, which may influence its absorption and bioavailability in the body"}}

Preparation & Dosage

No clinically studied dosage ranges are available for any form of humulene (extract, powder, or standardized preparations). Human clinical data are absent, preventing evidence-based dosage recommendations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Beta-caryophyllene, other sesquiterpenes, hop extracts, clove essential oil

Safety & Interactions

No formal human safety studies have been conducted on isolated α-humulene supplementation, leaving its tolerability profile largely undefined. Because humulene may inhibit COX enzymes, theoretical interactions with NSAIDs, anticoagulants such as warfarin, and antiplatelet drugs cannot be excluded and warrant caution. Pregnancy and lactation safety data are entirely absent, and use during these periods should be avoided until evidence exists. Individuals with known sesquiterpene or terpene sensitivities, or those using cytochrome P450-metabolized medications, should consult a healthcare provider before use.